AI - Relay Therapeutics

Transforming drug discovery through leading-edge protein motion analysis for life-changing medicines.

Name
Relay Therapeutics -https://relaytx.com/
Last Audited At

About Relay Therapeutics

Relay Therapeutics is a pioneering biotechnology company transforming the landscape of drug discovery. They are creating new possibilities by unlocking the secrets of protein motion, an approach that goes beyond traditional methods and allows for high-definition visualization of protein dynamics. With a mission to "drug the undruggable," Relay Therapeutics is advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology and genetic diseases. The company's integrated, collaborative, and entrepreneurial team is dedicated to bringing life-changing medicines to patients as quickly as possible. By leveraging their leading-edge experimental and computational approaches through the Dynamo Platform, Relay Therapeutics aims to more effectively target previously intractable or inadequately drugged targets. Their unyielding commitment to relentless innovation and humanity sets them apart in the field of drug discovery.

Screenshot of Relay Therapeutics Website

Was this page helpful?

More companies

Observe.ai

Transform customer experiences with AI-powered Contact Center QA and remote workforce tools, providing data for agent training, process improvement, and business expansion.

Read more

DreamData

Unlocking actionable insights with B2B revenue attribution.

Read more

Talend

Transform business data into intelligent insights with Talend's advanced data integration and management solutions across industries.

Read more

Tell us about your project

Our Hubs

London, United Kingdom

A global AI hotspot, thrives on innovation, diverse talent, and a dynamic tech ecosystem, offering unparalleled opportunities for AI engineers.

Munich, Germany

A vibrant AI hub, merges cutting-edge technology with rich cultural experiences, creating an inspiring environment for AI engineers.